RAPIDITY OF SYMPTOM CONTROL WITH UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES

Edward V. Loftus  ¹     Ken Takeuchi  ²     Xiang Gao  ³     Remo Panaccione  ⁴     Silvio Danese  ⁵     Dapo Ilo  ⁶     Tricia Finney-Hayward     Wen Zhou     Charles Phillips     Xuan Yao     Severine Vermeire  ^7    
1 Mayo Clinic, Rochester, United States
² Tsujinaka Hospital Kashiwanoha, Kashiwa, Japan
³ The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
⁴ University of Calgary, Calgary, Canada
⁵ Humanitas University and Humanitas Research Hospital, Milan, Italy
⁶ AbbVie Inc., North Chicago, United States
⁷ University Hospital Leuven, Leuven, Belgium

Topic
IBD

Session
IBD: Clinical trials II (small molecules)

Conference
UEG Week Virtual 2021

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 8)